CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $99.46 billion. The enterprise value is $169.98 billion.
| Market Cap | 99.46B |
| Enterprise Value | 169.98B |
Important Dates
The next confirmed earnings date is Tuesday, February 10, 2026, before market open.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | Jan 22, 2026 |
Share Statistics
CVS Health has 1.27 billion shares outstanding. The number of shares has decreased by -0.37% in one year.
| Current Share Class | 1.27B |
| Shares Outstanding | 1.27B |
| Shares Change (YoY) | -0.37% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 89.02% |
| Float | 1.27B |
Valuation Ratios
The trailing PE ratio is 211.33 and the forward PE ratio is 11.39. CVS Health's PEG ratio is 0.75.
| PE Ratio | 211.33 |
| Forward PE | 11.39 |
| PS Ratio | 0.25 |
| Forward PS | 0.24 |
| PB Ratio | 1.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.80 |
| P/OCF Ratio | 10.92 |
| PEG Ratio | 0.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.52, with an EV/FCF ratio of 27.01.
| EV / Earnings | 362.43 |
| EV / Sales | 0.43 |
| EV / EBITDA | 11.52 |
| EV / EBIT | 16.75 |
| EV / FCF | 27.01 |
Financial Position
The company has a current ratio of 0.83, with a Debt / Equity ratio of 1.12.
| Current Ratio | 0.83 |
| Quick Ratio | 0.59 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | 4.62 |
| Debt / FCF | 12.99 |
| Interest Coverage | 3.28 |
Financial Efficiency
Return on equity (ROE) is 0.58% and return on invested capital (ROIC) is 1.03%.
| Return on Equity (ROE) | 0.58% |
| Return on Assets (ROA) | 2.50% |
| Return on Invested Capital (ROIC) | 1.03% |
| Return on Capital Employed (ROCE) | 6.24% |
| Weighted Average Cost of Capital (WACC) | 4.10% |
| Revenue Per Employee | $1.31M |
| Profits Per Employee | $1,563 |
| Employee Count | 300,000 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 18.54 |
Taxes
In the past 12 months, CVS Health has paid $2.48 billion in taxes.
| Income Tax | 2.48B |
| Effective Tax Rate | 85.28% |
Stock Price Statistics
The stock price has increased by +40.69% in the last 52 weeks. The beta is 0.50, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +40.69% |
| 50-Day Moving Average | 78.66 |
| 200-Day Moving Average | 72.28 |
| Relative Strength Index (RSI) | 50.83 |
| Average Volume (20 Days) | 10,537,644 |
Short Selling Information
The latest short interest is 18.76 million, so 1.48% of the outstanding shares have been sold short.
| Short Interest | 18.76M |
| Short Previous Month | 22.92M |
| Short % of Shares Out | 1.48% |
| Short % of Float | 1.48% |
| Short Ratio (days to cover) | 3.02 |
Income Statement
In the last 12 months, CVS Health had revenue of $391.69 billion and earned $469.00 million in profits. Earnings per share was $0.37.
| Revenue | 391.69B |
| Gross Profit | 52.30B |
| Operating Income | 10.15B |
| Pretax Income | 2.91B |
| Net Income | 469.00M |
| EBITDA | 14.75B |
| EBIT | 10.15B |
| Earnings Per Share (EPS) | $0.37 |
Balance Sheet
The company has $11.23 billion in cash and $81.75 billion in debt, with a net cash position of -$70.52 billion or -$55.55 per share.
| Cash & Cash Equivalents | 11.23B |
| Total Debt | 81.75B |
| Net Cash | -70.52B |
| Net Cash Per Share | -$55.55 |
| Equity (Book Value) | 73.11B |
| Book Value Per Share | 57.42 |
| Working Capital | -15.59B |
Cash Flow
In the last 12 months, operating cash flow was $9.11 billion and capital expenditures -$2.82 billion, giving a free cash flow of $6.29 billion.
| Operating Cash Flow | 9.11B |
| Capital Expenditures | -2.82B |
| Free Cash Flow | 6.29B |
| FCF Per Share | $4.96 |
Margins
Gross margin is 13.35%, with operating and profit margins of 2.59% and 0.12%.
| Gross Margin | 13.35% |
| Operating Margin | 2.59% |
| Pretax Margin | 0.74% |
| Profit Margin | 0.12% |
| EBITDA Margin | 3.77% |
| EBIT Margin | 2.59% |
| FCF Margin | 1.61% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 3.40%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 3.40% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 717.46% |
| Buyback Yield | 0.37% |
| Shareholder Yield | 3.77% |
| Earnings Yield | 0.47% |
| FCF Yield | 6.33% |
Analyst Forecast
The average price target for CVS Health is $93.05, which is 18.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $93.05 |
| Price Target Difference | 18.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 4.55% |
| EPS Growth Forecast (5Y) | 20.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.18 |
| Piotroski F-Score | 6 |